CAS Number:
N/A
Molecular formula:
C4H7N7
Molecular weight:
153.15
Email:sale@hdimpurity.com
Price wire negotiation
Shenzhen Hengfeng Wanda Pharmaceutical Technology is a professional supplier of drug impurity control products. Products with short delivery time, covering more than 90% of cutting-edge generic drug projects; All products must check LCMS and HPLC within a year.The company has 300 flat warehouse, 42 sets of -20℃ refrigerator; Under the brands "H&D" and "Molcoo", we provide customized synthesis and preparation of small molecule compounds. The company has its own research and development center, focusing on providing pharmaceutical research and development units with new drug and generic drug registration and application of chemical products, including drug standards, drug impurity reference products, characteristic intermediates, analysis and testing and customized compound synthesis services. The company can provide professional technical services.
The company focuses on providing pharmaceutical research and development units with new drugs and generic drug registration and application of chemical products, including drug impurity reference products, standard products, pharmaceutical intermediates, and drug impurity preparation, separation and purification business. Our company is located in Wuhan, a city with abundant talents and a thoroughfare of nine provinces.The company enjoys more rich academic foundation and convenient and fast logistics speed.
Our delivery standard is not less than 98% purity (HPLC).If the purity is less than 98%, we will give special instructions to the customer. All standard products will be provided by Molcoo quality assurance and related certificates (COA), H-NMR, MS, HPLC and other structure confirmation to meet the basic needs.Customers can also test C-NMR, QNMR, IR, etc., according to their own needs, we can also provide atlas analysis services for new and old customers Provides a simple synthetic route.
Impurity Sales Manager: Mr. Sun
Email:sale@hdimpurity.com
Price wire negotiation
China
